« Back
Home /
Favipiravir

Favipiravir

Item no.	TMO-T6833-5mg
Manufacturer	TargetMol
CASRN	259793-96-9
Amount	5 mg
Quantity options	100 mg 10 mM x 1 mL (in DMSO) 10 mg 1 mL 25 mg 2 mg 500 mg 50 mg 5 mg
Category	Infectious Diseases Viral Infections Coronavirus (COVID-19) Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Citations	1.Favipiravir: RNA-directed RNA polymerase NS5B inhibitor treatment of influenza A By Reviriego, C.From Drugs of the Future (2010), 35(9), 713-717.
Smiles	NC(=O)c1nc(F)cnc1O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide, T-705
Shipping condition	Cool pack
Available
Manufacturer - Targets	Influenza Virus\|\|\|DNA/RNA Synthesis\|\|\|SARS-CoV
Shipping Temperature	cool pack
Storage Conditions	-20°
Molecular Weight	157, 1
Target names or alias	T-705 , 6-Fluoro-3-oxo-3, 4-dihydropyrazine-2-carboxamide
Description	Favipiravir (T-705) (T-705), an effective and selective RNA-dependent RNA polymerase inhibitor, are applied to treat influenza virus infections.
Pathways	DNA Damage/DNA Repair\|\|\|Cell Cycle/Checkpoint\|\|\|Microbiology/Virology

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T6833-5mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Request delivery time